| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,369 |
1,304 |
$96K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,408 |
2,303 |
$77K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
721 |
693 |
$50K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,021 |
981 |
$31K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,182 |
850 |
$21K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,296 |
1,254 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
407 |
394 |
$13K |
| 87634 |
|
231 |
226 |
$12K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,150 |
1,479 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
86 |
75 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
109 |
80 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
271 |
257 |
$2K |
| 81002 |
|
1,300 |
949 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
46 |
42 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
103 |
97 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12 |
12 |
$126.98 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
14 |
12 |
$3.76 |